TOMASSETTI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 4.061
AS - Asia 3.261
EU - Europa 2.334
SA - Sud America 733
AF - Africa 61
OC - Oceania 44
Totale 10.494
Nazione #
US - Stati Uniti d'America 4.009
RU - Federazione Russa 1.397
CN - Cina 956
SG - Singapore 893
BR - Brasile 588
HK - Hong Kong 526
KR - Corea 385
IT - Italia 294
VN - Vietnam 245
IE - Irlanda 172
DE - Germania 94
SE - Svezia 88
IN - India 75
FI - Finlandia 66
ID - Indonesia 56
AR - Argentina 52
PL - Polonia 48
FR - Francia 47
GB - Regno Unito 45
AU - Australia 43
EC - Ecuador 30
JO - Giordania 25
BD - Bangladesh 21
NL - Olanda 21
CA - Canada 19
MX - Messico 16
PE - Perù 15
ZA - Sudafrica 14
CO - Colombia 13
IQ - Iraq 13
EG - Egitto 12
UA - Ucraina 11
CL - Cile 10
VE - Venezuela 10
AT - Austria 8
JP - Giappone 8
PK - Pakistan 8
PY - Paraguay 8
BJ - Benin 7
ES - Italia 7
MA - Marocco 7
CI - Costa d'Avorio 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
KE - Kenya 4
KZ - Kazakistan 4
RS - Serbia 4
TN - Tunisia 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
BE - Belgio 3
BG - Bulgaria 3
BO - Bolivia 3
IL - Israele 3
JM - Giamaica 3
KG - Kirghizistan 3
PA - Panama 3
RO - Romania 3
SC - Seychelles 3
TR - Turchia 3
GE - Georgia 2
HN - Honduras 2
LV - Lettonia 2
PT - Portogallo 2
SV - El Salvador 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BW - Botswana 1
GA - Gabon 1
HU - Ungheria 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
MM - Myanmar 1
MR - Mauritania 1
MT - Malta 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 10.494
Città #
Santa Clara 2.008
Singapore 650
Hong Kong 481
Hefei 426
Seoul 385
Ashburn 351
Dublin 166
Fairfield 158
Ho Chi Minh City 102
Beijing 98
Moscow 98
Altamura 92
Lawrence 92
Los Angeles 78
Florence 71
Buffalo 62
Dallas 62
Houston 56
Hanoi 53
Princeton 51
Kent 46
Medford 45
Warsaw 44
Melbourne 43
Cambridge 42
Wilmington 41
Woodbridge 40
Jakarta 39
São Paulo 39
Munich 38
New York 37
Chandler 35
Seattle 32
San Diego 30
The Dalles 30
Lappeenranta 29
Mumbai 28
Turku 25
Boston 24
Chicago 22
Bengaluru 21
Rio de Janeiro 20
Shanghai 20
Ann Arbor 19
Frankfurt am Main 18
Boardman 17
Shenzhen 16
Milan 14
Paris 14
Belo Horizonte 13
Curitiba 12
Helsinki 12
Porto Alegre 12
Guayaquil 10
Amsterdam 9
Brasília 9
Da Nang 9
Haiphong 9
Marcará 9
Denver 8
Guangzhou 8
London 8
Salt Lake City 8
Santo André 8
Andover 7
Cairo 7
Cotonou 7
Hải Dương 7
Montes Claros 7
Norwalk 7
Quito 7
Abidjan 6
Biên Hòa 6
Chennai 6
Dong Ket 6
Medellín 6
Nuremberg 6
Poplar 6
Rome 6
San Francisco 6
Tampa 6
Thái Nguyên 6
Tokyo 6
Toronto 6
Yubileyny 6
Brooklyn 5
Can Tho 5
Caxias do Sul 5
Hangzhou 5
Hillsboro 5
Johannesburg 5
Lauterbourg 5
Osasco 5
Phoenix 5
Porto Seguro 5
Ribeirão Preto 5
Stockholm 5
Sumaré 5
Tashkent 5
Uberlândia 5
Totale 6.760
Nome #
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study 185
Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes 182
Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes 154
Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study 150
The ThinICE protocol: the combination of cryobiopsy and ultraThin bronchoscopy for the peripheral lung nodule 148
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 146
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 145
Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis–Interstitial Lung Disease: A Systematic Review 141
Presentation and progression of MPO-ANCA interstitial lung disease 139
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19 138
Images in Sarcoidosis: new section of our Journal 137
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 137
Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients 136
COUNTERPOINT: Should Surgical Lung Biopsy Still Be Performed for Interstitial Lung Disease Evaluation? No 131
Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium 130
Assessing coronavirus disease 2019 (COVID-19) transmission to healthcare personnel: The global ACT-HCP case-control study 129
Laryngotracheal aspiration test reduce the false negative rate in patients with suspected SARS-COV-2 pneumonia despite a negative nasopharyngeal swab 127
Cryobiopsy in the diagnosis of bronchiolitis: a retrospective analysis of twenty-three consecutive patients 122
Improvement in the management of nontuberculous mycobacteria after lobar collapse therapy with Endobronchial valves (EBV) 119
Ultrasonography for the Diagnosis of Pneumothorax after Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Diseases 119
Impact of Lung Biopsy Information on Treatment Strategy of Patients with Interstitial Lung Diseases 117
Airway-Centered Pleuroparenchymal Fibroelastosis Associated with Non-Necrotizing Granulomas: A Rare New Entity 117
Assessment of lung cancer development in idiopathic pulmonary fibrosis patients using quantitative high-resolution computed tomography: a retrospective analysis 117
Cryobiopsies are diagnostic in Pleuroparenchymal and Airway-centered Fibroelastosis 116
Idiopathic pulmonary fibrosis: Prognostic impact of histologic honeycombing in transbronchial lung cryobiopsy 115
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database 114
Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosis 114
Predictors of Worse Prognosis in Young and Middle-Aged Adults Hospitalized with COVID-19 Pneumonia: A Multi-Center Italian Study (COVID-UNDER50) 114
Report standardization in transbronchial lung cryobiopsy 113
Laboratory data and broncho-alveolar lavage on Covid-19 patients with no intensive care unit admission: Correlation with chest CT features and clinical outcomes 112
Antiviral combination regimens as rescue therapy in immunocompromised hosts with persistent COVID-19 112
Incidental discovery of interstitial lung disease: Diagnostic approach, surveillance and perspectives 111
Supine vs prone position in mild to moderate COVID-19 pneumonia: The impact of proning on computed tomography findings 110
Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants 110
Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study 110
European Respiratory Society guidelines on transbronchial lung cryobiopsy in the diagnosis of interstitial lung diseases 109
Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis 109
Pulmonary vein stenosis mimicking interstitial lung disease 107
How might transbronchial cryobiopsy improve diagnosis and treatment of diffuse parenchymal lung disease patients? 106
Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure 105
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective 105
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection 104
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 104
Historical eye on IPF: a cohort study redefining the mortality scenario 104
A pilot study on the use of the super dimension navigation system for optimal cryobiopsy location in interstitial lung disease diagnostics 104
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial 103
The prognostic role of gender-age-physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 102
Invasive diagnostic techniques in idiopathic interstitial pneumonias 101
Editorial: Are we ready for prime time? 101
Big Things Have Small Beginnings: Clinical Implications of Early Interstitial Lung Disease 101
A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis 100
Microbiota and IPF: hidden and detected relationships 100
Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Disease: Comparison between Biopsy from 1 Segment and Biopsy from 2 Segments-Diagnostic Yield and Complications 99
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 98
Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do? 98
An HIV + patient with visceral enlarged lymphnodes 98
"Alveolar stem cell exhaustion, fibrosis and bronchiolar proliferation" related entities. A narrative review 97
Nintedanib in progressive fibrosing interstitial lung diseases 97
Suggestions for improving clinical utility of future guidelines for diagnosis and management of idiopathic pulmonary fibrosis: results of a Delphi survey 97
Transbronchial cryobiopsy: an effective tool in the diagnosis of lymphoproliferative disorders of the lung 96
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia 95
Transbronchial Cryobiopsy in the Diagnosis of Diffuse Lung Disease 95
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 95
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here? 94
Transbronchial cryobiopsy increases diagnostic confidence in interstitial lung disease: a prospective multicentre trial 94
Transbronchial Cryobiopsy in Diffuse Lung Disease: Update for the Pathologist 92
From "traction bronchiectasis" to honeycombing in idiopathic pulmonary fibrosis: A spectrum of bronchiolar remodeling also in radiology? 92
Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis 92
Pulmonary fibrolysis in a patient with idiopathic pulmonary fibrosis: improvement of clinical and radiological pattern after treatment with pirfenidone 91
Safety and Diagnostic Yield of Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Diseases: A Comparative Study versus Video-Assisted Thoracoscopic Lung Biopsy and a Systematic Review of the Literature 91
The SARS-CoV-2 viral load in COVID-19 patients is lower on face mask filters than on nasopharyngeal swabs 91
Diffuse parenchymal lung disease 90
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe 90
Oxygen in patients with fibrotic interstitial lung disease: aninternational Delphi survey 89
"Gallia est omnis divisa in partes tres": Is it time to divide Pleuroparenchymal Fibroelastosis in three different forms? 89
Update of penetrance estimates in Birt-Hogg-Dubé syndrome 87
Idiopathic Pulmonary Fibrosis 87
Quality of life in idiopathic pulmonary fibrosis: The impact of sleep disordered breathing 86
Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis 85
Detection and early referral of patients with interstitial lung abnormalities: an expert survey initiative 85
Stratification of long-term outcome in stable idiopathic pulmonary fibrosis by combining longitudinal computed tomography and forced vital capacity 85
OSA and Prolonged Oxygen Desaturation During Sleep are Strong Predictors of Poor Outcome in IPF 84
Diagnostic likelihood thresholds that define a working diagnosis of idiopathic pulmonary fibrosis 84
Rebuttal From Dr Tomassetti et al 83
Circulating inflammatory cytokines predict severity disease in hospitalized COVID-19 patients: A prospective multicenter study of the European DRAGON consortium 83
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities 82
New idiopathic pulmonary fibrosis guidelines: Are cryobiopsy and surgery competitive in clinical practice? 82
Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis: An International Modified Delphi Survey 82
Unsupervised machine learning identifies predictive progression markers of IPF 79
Pinocchio and Interstitial Lung Abnormalities: Is It Just Another Lie? 79
Time to Trust Transbronchial Cryobiopsy in Identification of Usual Interstitial Pneumonia Pattern 79
Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype 78
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review 77
Angiosarcoma in the chest: radiologic-pathologic correlation: Case report 77
Long-term safety of pirfenidone: Results of the prospective, observational PASSPORT study 76
Transbronchial cryobiopsy in diffuse parenchymal lung diseases 76
Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients 74
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases 70
Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis 66
Role of fibrogenesis of gastroesophageal reflux and microaspiration in a patient with 12 years of radiologic follow-up 64
Totale 10.432
Categoria #
all - tutte 32.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021190 0 0 0 0 0 71 19 8 27 21 4 40
2021/2022523 6 205 13 12 7 28 35 16 4 33 65 99
2022/2023659 75 195 31 22 7 101 89 8 66 28 28 9
2023/2024372 3 38 61 29 32 26 7 72 17 59 21 7
2024/20255.066 114 303 251 713 1.526 902 143 326 189 107 170 322
2025/20263.782 635 965 880 711 531 60 0 0 0 0 0 0
Totale 10.627